Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 13Breast Neoplasms 9Rectal Neoplasms 3Neoplasm Metastasis 2Colonic Neoplasms 2Upper Gastrointestinal Tumours 1TTP 1Stomach Neoplasms 1Recurrence 1Patient Acceptance of Health Care 1Pancreatic Cancer Non-resectable 1Locally Advanced Colorectal Cancer 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1HER-2 Positive Gastric Cancer 1Frailty 1

Interventions

Oxaliplatin 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Locally Advanced Colorectal Cancer × Capecitabine × Clear all
NCT06550453 2024-11-12

Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer

Xijing Hospital

Phase 4 Recruiting
20 enrolled
Gastrointestinal

Locally Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡